Testosterone

Testosterone is a 19-carbon steroid hormone produced primarily in the Leydig cells of the testes in men, and in smaller amounts in the adrenal glands and ovaries in women. It drives the development of male secondary sexual characteristics, regulates muscle mass and bone density, governs libido and mood, and controls red blood cell production across both sexes. In a clinical context, testosterone replacement therapy (TRT) is a well-established, FDA-approved treatment for hypogonadism — clinically low testosterone — which affects an estimated 2–4 million men in the United States. In this context, testosterone is a legitimate medication with extensive safety data and a track record spanning more than eight decades. In a performance context, supraphysiological testosterone doses have been used by athletes and bodybuilders since the 1950s. At performance doses, testosterone's anabolic effects — muscle protein synthesis, nitrogen retention, increased red blood cell production — are substantially more pronounced than at TRT doses, accompanied by proportionally more significant side effect risk. The compound is available in multiple ester forms (Enanthate, Cypionate, Propionate, Undecanoate) that differ primarily in their pharmacokinetic profiles — specifically how quickly they are released from the injection site and cleared from the body.

Muscle mass and strength gains represent testosterone's most documented performance benefit. Controlled studies have demonstrated dose-dependent increases in lean body mass and strength even in the absence of exercise, with gains further amplified by resistance training. At TRT doses (100–200 mg/week), improvements in body composition are modest and clinically meaningful; at performance doses (300–600 mg/week), gains are substantially more pronounced. Mood, energy, and libido restoration are the primary drivers of TRT adoption. Low testosterone is associated with fatigue, depression, cognitive fog, and sexual dysfunction; restoring physiological levels produces correspondingly significant improvements in these domains. These benefits are established across hundreds of clinical trials. Red blood cell production elevation — erythropoiesis — improves oxygen delivery to muscle tissue and is one mechanism behind improved athletic endurance at supraphysiological doses. Bone density maintenance and improvement are clinically established benefits, making testosterone relevant in the context of osteoporosis prevention as well as performance.

HPTA suppression is the most significant physiological consequence of exogenous testosterone. The hypothalamic-pituitary-testicular axis detects elevated testosterone via negative feedback and shuts down endogenous production. At TRT doses with indefinite continuation, this suppression is managed by continuous treatment; at performance doses followed by discontinuation, post-cycle therapy (PCT) is required to restore endogenous production. Estrogen conversion (aromatization) occurs as testosterone is converted to estradiol by the aromatase enzyme in fat and other tissues. Elevated estrogen causes water retention, gynecomastia (breast tissue development), mood instability, and reduced libido if unmanaged. Aromatase inhibitors (AIs) such as anastrozole or letrozole are commonly used to manage estrogen levels. Cardiovascular effects at performance doses are the primary long-term safety concern. Supraphysiological testosterone causes unfavorable changes in lipid profiles (reduced HDL, elevated LDL), increased red blood cell count that raises blood viscosity and clotting risk, and can cause left ventricular hypertrophy with chronic use. These risks are substantially lower at TRT doses. Androgenic side effects — acne, oily skin, accelerated male pattern baldness, and body hair changes — are dose-dependent and genetically variable. Individuals with androgenic sensitivity experience these more prominently.

TRT dosing: 100–200 mg per week of Testosterone Enanthate or Cypionate, typically administered as one or two injections per week to maintain stable blood levels. Physician-prescribed TRT is titrated based on total testosterone and symptom response. Performance dosing: 300–500 mg/week is common for first and intermediate cycles. Doses above 600 mg/week are associated with disproportionately increasing side effects relative to additional benefit. Experienced users may run higher doses but with correspondingly more aggressive ancillary management. Ester selection: Testosterone Enanthate (half-life ~4–5 days) and Testosterone Cypionate (half-life ~8–12 days) are the most commonly used — both administered once or twice weekly. Testosterone Propionate (half-life ~2–3 days) requires more frequent injections but allows faster blood level adjustment. Ancillary compounds: Performance cycles typically include an aromatase inhibitor (anastrozole 0.25–0.5 mg every other day or letrozole 0.1–0.25 mg every other day) and conclude with PCT using SERMs (nolvadex 20–40 mg/day and/or clomid 25–50 mg/day for 4–6 weeks).

United States: Testosterone is a Schedule III controlled substance under the Anabolic Steroids Control Act. Possession without a valid prescription is a federal crime. Physician-prescribed TRT is entirely legal and widely practiced. Obtaining testosterone without a prescription via online pharmacies or black market is illegal. Medical access: Hypogonadism diagnosis (typically total testosterone below 300 ng/dL with symptoms) qualifies for prescription testosterone in the US. Telehealth TRT clinics have dramatically expanded access to legitimate testosterone prescriptions. WADA / Sports: Testosterone is a prohibited substance in athletic competition at supraphysiological doses. TRT use in competitive sports requires a Therapeutic Use Exemption (TUE).

Testosterone as a base: Testosterone is the foundational compound in virtually every anabolic steroid cycle. Its role as the primary endogenous androgen means it is used to maintain baseline androgen levels while other compounds are added for specific effects. Testosterone + Nandrolone (Deca): Classic bulking stack. Testosterone provides the androgenic base; Nandrolone adds lean mass with joint lubrication benefits. The combination requires careful prolactin management. Testosterone + Anavar: Testosterone base for HPTA support; Anavar adds strength and lean mass without significant estrogenic activity. A common lean bulking or body recomposition stack. Testosterone + SARMs: Some users use low-dose testosterone (TRT level) as a hormonal foundation while adding SARMs for specific anabolic effects, aiming to minimize total hormonal disruption.

Testosterone — Common Questions